CompletedNCT05195372

Effectivity and Safety of Different Anticoagulants in Patients With Thromboembolic Antiphospholipid Syndrome

Studying Antiphospholipid syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Cardioangiologisches Centrum Bethanien
Principal Investigator
Edelgard Lindhoff-Last
CardioAngiology Center Bethanienhospital (CCB)Frankfurt
Enrollment
80 enrolled
Eligibility
18-100 years · All sexes
Timeline
2015 – 2022

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05195372 on ClinicalTrials.gov

Other trials for Antiphospholipid syndrome

Additional recruiting or active studies for the same condition.

See all trials for Antiphospholipid syndrome →

← Back to all trials